These results also suggest that ADAMTS12 may promote cancer progression by affecting the phosphorylation levels of mTOR and 4E-BP1 in the PI3K signaling pathway, and then induce the infiltration of B cells, macrophages, and other immune cells. Here, ADAMTS12 is linked to cancer.